170 related articles for article (PubMed ID: 33821347)
1. Clinical Significance of Mesenteric Lymph Node Involvement in the Pattern of Liver Metastasis in Patients with Ovarian Cancer.
Tanaka K; Shimada Y; Nishino K; Yoshihara K; Nakano M; Kameyama H; Enomoto T; Wakai T
Ann Surg Oncol; 2021 Nov; 28(12):7606-7613. PubMed ID: 33821347
[TBL] [Abstract][Full Text] [Related]
2. Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: prognostic role and clinical considerations.
Gallotta V; Fanfani F; Fagotti A; Chiantera V; Legge F; Gueli Alletti S; Nero C; Margariti AP; Papa V; Alfieri S; Ciccarone F; Scambia G; Ferrandina G
Ann Surg Oncol; 2014 Jul; 21(7):2369-75. PubMed ID: 24558070
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of mesenteric lymph nodes involvement in patients undergoing posterior pelvic exenteration during radical or supra-radical surgery for advanced ovarian cancer.
Berretta R; Capozzi VA; Sozzi G; Volpi L; Ceni V; Melpignano M; Giordano G; Marchesi F; Monica M; Di Serio M; Riccò M; Ceccaroni M
Arch Gynecol Obstet; 2018 Apr; 297(4):997-1004. PubMed ID: 29380107
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer.
Gouy S; Goetgheluck J; Uzan C; Duclos J; Duvillard P; Morice P
Eur J Surg Oncol; 2012 Feb; 38(2):170-5. PubMed ID: 22104389
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of Mesenteric Lymph Node Status on Digestive Resection Specimens During Cytoreductive Surgery for Ovarian Peritoneal Metastases.
Channawi A; Pop FC; Khaled C; Gomez MG; Moreau M; Polastro L; Veys I; Liberale G
Ann Surg Oncol; 2024 Jan; 31(1):605-613. PubMed ID: 37865938
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer.
Angeles MA; Ferron G; Cabarrou B; Balague G; Martínez-Gómez C; Gladieff L; Pomel C; Martinez A
Eur J Surg Oncol; 2019 Aug; 45(8):1410-1416. PubMed ID: 30857876
[TBL] [Abstract][Full Text] [Related]
7. Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer.
Chen Y; Zhang L; Tian J; Fu X; Ren X; Hao Q
Int J Gynecol Cancer; 2013 Jan; 23(1):157-63. PubMed ID: 23221732
[TBL] [Abstract][Full Text] [Related]
8. Large metastatic lymph node size, especially more than 2 cm: independent predictor of poor prognosis in node-positive gastric carcinoma.
Cheong O; Oh ST; Kim BS; Yook JH; Kim JH; Im JT; Park GC
World J Surg; 2008 Feb; 32(2):262-6. PubMed ID: 18064519
[TBL] [Abstract][Full Text] [Related]
9. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
[TBL] [Abstract][Full Text] [Related]
10. Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma.
Salani R; Diaz-Montes T; Giuntoli RL; Bristow RE
Ann Surg Oncol; 2007 Dec; 14(12):3552-7. PubMed ID: 17896149
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors and Prognostic Impact of Mediastinal Lymph Node Metastases in Patients with Esophagogastric Junction Cancer.
Shiraishi O; Yasuda T; Kato H; Iwama M; Hiraki Y; Yasuda A; Shinkai M; Kimura Y; Imano M
Ann Surg Oncol; 2020 Oct; 27(11):4433-4440. PubMed ID: 32409967
[TBL] [Abstract][Full Text] [Related]
12. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
[TBL] [Abstract][Full Text] [Related]
13. Canine anal sac gland carcinoma with regional lymph node metastases treated with sacculectomy and lymphadenectomy: Outcome and possible prognostic factors.
Tanis JB; Simlett-Moss AB; Ossowksa M; Maddox TW; Guillem J; Lopez-Jimenez C; Polton G; Burrow R; Finotello R
Vet Comp Oncol; 2022 Mar; 20(1):276-292. PubMed ID: 34590408
[TBL] [Abstract][Full Text] [Related]
14. Significance of numbers of metastatic and removed lymph nodes in FIGO stage IB1 to IIA cervical cancer: Primary surgical treatment versus neoadjuvant chemotherapy before surgery.
Kim HS; Kim JH; Chung HH; Kim HJ; Kim YB; Kim JW; Park NH; Song YS; Kang SB
Gynecol Oncol; 2011 Jun; 121(3):551-7. PubMed ID: 21334733
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Factors Affecting Lymph Node Metastasis in Clinical Stage I-II Epithelial Ovarian Cancer.
Erdem B; Yüksel IT; Peker N; Ulukent SC; Aşıcıoğlu O; Özaydin IY; Ülker V; Akbayir O
Oncol Res Treat; 2018; 41(7-8):444-448. PubMed ID: 29975960
[TBL] [Abstract][Full Text] [Related]
16. Impact of Metastatic Lymph Node to Total Lymph Node Ratio on Survival of Endometrial Cancer Patients.
Tangjitgamol S; Kittisiam T; Sriraumpuch J
Gynecol Obstet Invest; 2019; 84(5):463-471. PubMed ID: 30836353
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
[TBL] [Abstract][Full Text] [Related]
18. Hepatoceliac Lymph Node Involvement in Advanced Ovarian Cancer Patients: Prognostic Role and Clinical Considerations.
Gallotta V; Ferrandina G; Vizzielli G; Conte C; Lucidi A; Costantini B; De Rose AM; Di Giorgio A; Zannoni GF; Fagotti A; Scambia G; Chiantera V
Ann Surg Oncol; 2017 Oct; 24(11):3413-3421. PubMed ID: 28718034
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of lymph node status for patients with ampullary adenocarcinoma after radical resection followed by adjuvant treatment.
Kwon J; Kim K; Chie EK; Kim BH; Jang JY; Kim SW; Oh DY; Bang YJ
Eur J Surg Oncol; 2017 Sep; 43(9):1690-1696. PubMed ID: 28648977
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
Bilici A; Selcukbiricik F
Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
